AAAAAA

   
Results: 1-13 |
Results: 13
Inhibitory effect of JTV-803, a new cyclic guanidine derivative, on factorXa in vitro and in vivo
Authors: Hayashi, M Hamada, A Okaya, Y Wakitani, K Aisaka, K
Citation: M. Hayashi et al., Inhibitory effect of JTV-803, a new cyclic guanidine derivative, on factorXa in vitro and in vivo, EUR J PHARM, 428(2), 2001, pp. 163-168
JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues
Authors: Wakitani, K Tazaki, H Matsushita, M Iwamura, H
Citation: K. Wakitani et al., JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues, INFLAMM RES, 49(3), 2000, pp. 117-122
Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta 474) by a novel COX-2 inhibitor, JTE-522
Authors: Sasai, H Masaki, M Wakitani, K
Citation: H. Sasai et al., Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta 474) by a novel COX-2 inhibitor, JTE-522, CARCINOGENE, 21(5), 2000, pp. 953-958
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
Authors: Okamoto, H Yonemori, F Wakitani, K Minowa, T Maeda, K Shinkai, H
Citation: H. Okamoto et al., A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits, NATURE, 406(6792), 2000, pp. 203-207
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats
Authors: Shibata, T Takeuchi, S Yokota, S Kakimoto, K Yonemori, F Wakitani, K
Citation: T. Shibata et al., Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats, BR J PHARM, 130(3), 2000, pp. 495-504
JTE-607, a novel inflammatory cytokine synthesis inhibitor without immunosuppression, protects from endotoxin shock in mice
Authors: Kakutani, M Takeuchi, K Waga, I Iwamura, H Wakitani, K
Citation: M. Kakutani et al., JTE-607, a novel inflammatory cytokine synthesis inhibitor without immunosuppression, protects from endotoxin shock in mice, INFLAMM RES, 48(8), 1999, pp. 461-468
Triglyceride-lowering effect of a novel insulin-sensitizing agent, JTT-501
Authors: Shibata, T Matsui, K Yonemori, F Wakitani, K
Citation: T. Shibata et al., Triglyceride-lowering effect of a novel insulin-sensitizing agent, JTT-501, EUR J PHARM, 373(1), 1999, pp. 85-91
Glucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compound
Authors: Furukawa, N Ohta, T Noguchi, T Yonemori, F Wakitani, K
Citation: N. Furukawa et al., Glucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compound, EUR J PHARM, 371(1), 1999, pp. 51-58
JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats
Authors: Ohta, T Furukawa, N Yonemori, F Wakitani, K
Citation: T. Ohta et al., JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats, EUR J PHARM, 367(1), 1999, pp. 91-99
Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative
Authors: Shibata, T Matsui, K Nagao, K Shinkai, H Yonemori, F Wakitani, K
Citation: T. Shibata et al., Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative, EUR J PHARM, 364(2-3), 1999, pp. 211-219
JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats
Authors: Ohta, T Furukawa, N Komuro, G Yonemori, F Wakitani, K
Citation: T. Ohta et al., JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats, BR J PHARM, 126(7), 1999, pp. 1674-1680
Profile of JTE-522 as a human cyclooxygenase-2 inhibitor
Authors: Wakitani, K Nanayama, T Masaki, M Matsushita, M
Citation: K. Wakitani et al., Profile of JTE-522 as a human cyclooxygenase-2 inhibitor, JPN J PHARM, 78(3), 1998, pp. 365-371
JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models
Authors: Shibata, T Matsui, K Yonemori, F Wakitani, K
Citation: T. Shibata et al., JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models, BR J PHARM, 125(8), 1998, pp. 1744-1750
Risultati: 1-13 |